Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Mitteregger

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
European Urology|December 22, 2006
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?Gero Kramer, Dieter Mitteregger, Michael Marberger
Vaccine|July 23, 2016
Meningococcal pneumoniaMatthias Vossen, Dieter Mitteregger, Christoph Steininger
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 28, 2014
High diversity of beta-lactamases in the General Hospital Vienna verified by whole genome sequencing and statistical analysisIvan Barišić, Dieter Mitteregger, Alexander M Hirschl, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 10, 2016
Corrigendum to "High diversity of beta-lactamases in the General Hospital Vienna verified by whole genome sequencing and statistical analysis" [Infect. Genet. Evol., Oct.;27 (2014) 408-417]Ivan Barišić, Dieter Mitteregger, Alexander M Hirschl, et al.
Pathogens (Basel, Switzerland)|April 23, 2022
A Variant Carbapenem Inactivation Method (CIM) for <i>Acinetobacter baumannii</i> Group with Shortened Time-to-Result: rCIM-ADieter Mitteregger, Julian Wessely, Ivan Barišić, et al.
Pathogens (Basel, Switzerland)|July 27, 2022
Reply to Muntean et al. Comment on "Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for <i>Acinetobacter baumannii</i> Group with Shortened Time-to-Result: rCIM-A. <i>Pathogens</i> 2022, <i>11</i>, 482"Dieter Mitteregger, Julian Wessely, Ivan Barišić, et al.
GMS Hygiene and Infection Control|October 7, 2014
Successful implementation of infection control strategies prevents P. aeruginosa transmission among cystic fibrosis patients inside the hospitalBenedikt Matt, Dieter Mitteregger, Sabine Renner, et al.
Journal of Clinical Microbiology|March 15, 2013
Neutralization of antimicrobial substances in new BacT/Alert FA and FN Plus blood culture bottlesDieter Mitteregger, Wolfgang Barousch, Marion Nehr, et al.
Emerging Infectious Diseases|January 27, 2016
Anaplasmataceae-Specific PCR for Diagnosis and Therapeutic Guidance for Symptomatic Neoehrlichiosis in Immunocompetent HostMichael Schwameis, Julia Auer, Dieter Mitteregger, et al.
Medical Microbiology and Immunology|June 11, 2011
High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissueDieter Mitteregger, Stephan W Aberle, Athanasios Makristathis, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
European Urology|December 22, 2006
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?Gero Kramer, Dieter Mitteregger, Michael Marberger
Vaccine|July 23, 2016
Meningococcal pneumoniaMatthias Vossen, Dieter Mitteregger, Christoph Steininger
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 28, 2014
High diversity of beta-lactamases in the General Hospital Vienna verified by whole genome sequencing and statistical analysisIvan Barišić, Dieter Mitteregger, Alexander M Hirschl, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 10, 2016
Corrigendum to "High diversity of beta-lactamases in the General Hospital Vienna verified by whole genome sequencing and statistical analysis" [Infect. Genet. Evol., Oct.;27 (2014) 408-417]Ivan Barišić, Dieter Mitteregger, Alexander M Hirschl, et al.
Pathogens (Basel, Switzerland)|April 23, 2022
A Variant Carbapenem Inactivation Method (CIM) for <i>Acinetobacter baumannii</i> Group with Shortened Time-to-Result: rCIM-ADieter Mitteregger, Julian Wessely, Ivan Barišić, et al.
Pathogens (Basel, Switzerland)|July 27, 2022
Reply to Muntean et al. Comment on "Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for <i>Acinetobacter baumannii</i> Group with Shortened Time-to-Result: rCIM-A. <i>Pathogens</i> 2022, <i>11</i>, 482"Dieter Mitteregger, Julian Wessely, Ivan Barišić, et al.
GMS Hygiene and Infection Control|October 7, 2014
Successful implementation of infection control strategies prevents P. aeruginosa transmission among cystic fibrosis patients inside the hospitalBenedikt Matt, Dieter Mitteregger, Sabine Renner, et al.
Journal of Clinical Microbiology|March 15, 2013
Neutralization of antimicrobial substances in new BacT/Alert FA and FN Plus blood culture bottlesDieter Mitteregger, Wolfgang Barousch, Marion Nehr, et al.
Emerging Infectious Diseases|January 27, 2016
Anaplasmataceae-Specific PCR for Diagnosis and Therapeutic Guidance for Symptomatic Neoehrlichiosis in Immunocompetent HostMichael Schwameis, Julia Auer, Dieter Mitteregger, et al.
Medical Microbiology and Immunology|June 11, 2011
High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissueDieter Mitteregger, Stephan W Aberle, Athanasios Makristathis, et al.
Pageof 3